Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Survival Curves01:18

Survival Curves

931
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
931
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Actuarial Approach01:20

Actuarial Approach

384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commensurate prior models with random effects for interval-censored data to accommodate historical controls.

Communications in statistics: Simulation and computation·2026
Same author

Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.

Transplantation and cellular therapy·2026
Same author

Statistical Methods for Chimeric Antigen Receptor Cell Therapy Outcomes: A Review and Practical Considerations.

Transplantation and cellular therapy·2026
Same author

Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Rforce: Random Forests for Composite Endpoints.

Statistics in medicine·2026
Same author

Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report.

Transplantation and cellular therapy·2025

Related Experiment Video

Updated: May 4, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Pseudo-value approach for comparing survival medians for dependent data.

Kwang Woo Ahn1, Franco Mendolia

  • 1Division of Biostatistics, Medical College of Wisconsin, 8701 Watertown Plank RoadMilwaukee, WI, 53226, U.S.A.

Statistics in Medicine
|December 17, 2013
PubMed
Summary

This study introduces a new pseudo-value method to compare survival medians, performing well for both independent and dependent cancer survival data. The approach offers improved performance for dependent data compared to existing methods.

Keywords:
censored dataclustered datapseudo-value approachsurvival median

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

7.7K

Related Experiment Videos

Last Updated: May 4, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

7.7K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Cancer Research

Background:

  • Survival median is a key metric for comparing treatment efficacy in cancer research.
  • Existing statistical tests primarily address independent survival data.
  • Dependent survival data, common in matched or clustered study designs, pose analytical challenges.

Purpose of the Study:

  • To propose and evaluate a novel pseudo-value approach for testing the equality of survival medians.
  • To assess the performance of this method for both independent and dependent survival data.
  • To provide a robust statistical tool for analyzing complex survival data in clinical research.

Main Methods:

  • Development of a pseudo-value method for survival median comparison.
  • Simulation studies to investigate Type I error and statistical power.
  • Evaluation across scenarios with independent and dependent survival data.
  • Application to a real-world bone marrow transplant dataset.

Main Results:

  • The proposed pseudo-value method demonstrates performance equivalent to existing methods for independent data.
  • The method shows superior performance for dependent survival data.
  • Simulation results confirm the method's reliability and power.

Conclusions:

  • The pseudo-value approach offers a versatile and effective tool for comparing survival medians.
  • This method addresses limitations of current approaches, particularly for dependent data structures.
  • The findings have implications for clinical trial design and analysis in oncology.